Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Movement disorder
ADR ID BADD_A02858
ADR Hierarchy
17      Nervous system disorders
17.01      Movement disorders (incl parkinsonism)
17.01.02      Dyskinesias and movement disorders NEC
17.01.02.010      Movement disorder
Description Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. [MeSH]
MedDRA Code 10028035
MeSH ID D009069
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Movement disorder | Movement disorder NOS | Movements disturbance NOS | Movement disorder (NOS) | Decreased arm swing | Impaired agility | Movement Disorders | Movement Disorder | Movement Disorder Syndromes | Movement Disorder Syndrome | Dyskinesia Syndromes | Dyskinesia Syndrome | Etat Marbre | Status Marmoratus
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02419Rosiglitazone--
BADD_D02424Valaciclovir0.000241%
BADD_D02426Ibandronate0.002135%
BADD_D02433Salbutamol0.000026%
BADD_D02436Atorvastatin--
BADD_D02437Diclofenamide0.000626%
BADD_D02440Lisdexamfetamine0.000486%
BADD_D02441Rasagiline0.007442%
BADD_D02451Pimavanserin0.001505%
BADD_D02456Vilazodone0.002970%
BADD_D02457Dexmethylphenidate0.000800%
BADD_D02459Dalteparin0.012704%
BADD_D02464Fingolimod0.039950%
BADD_D02467Naloxegol0.001220%
BADD_D02470Nintedanib--
BADD_D02484Istradefylline0.002486%
BADD_D02492Deflazacort--
BADD_D02507Deutetrabenazine0.003921%
BADD_D02511Siponimod0.001737%
The 6th Page    First    Pre   6    Total 6 Pages